Culver City, California March 18, 2013 The Coalition for Pulmonary Fibrosis (CPF), the Pulmonary Fibrosis Foundation (PFF), and the American Thoracic Society (ATS)the world's leading professional organization for pulmonary, critical care and sleep medicinetoday announced that the CPF and the PFF will again partner with the ATS to fund pulmonary fibrosis (PF) research. This is the seventh partnership grant between the three organizations.
"We are pleased to once again participate in the partnership grants with the ATS and the CPF. The Pulmonary Fibrosis Foundation feels that supporting these types of early stage grants can (and has) led to both an improved understanding of the pathophysiology of pulmonary fibrosis and to the development of more effective therapies. We applaud the leadership of the ATS in fostering these types of collaborations," said Daniel M. Rose, MD, Chairman and CEO of the PFF.
"We are honored to again join with ATS and the PFF to support critical research in pulmonary fibrosis," said Mishka Michon, Chief Executive Officer of the CPF. "The CPF is proud to be supporting these research efforts in an economic time of uncertainty regarding federal funding. It is an opportunity for the private sector to fill the gap and demonstrate our continued commitment to finding treatments and a cure for this devastating disease."
The patient organizations will each commit $20,000 per year to co-fund a two-year research grant to be awarded in 2013. The ATS will provide partial funding and management of the grant.
"We cannot advance in the area of pulmonary fibrosis treatment without sophisticated research. The research funded by these grants has helped advance our understanding of pulmonary fibrosis," said Jesse Roman, MD, member of the ATS Scientific Advisory Committee, Chair of PFF Research Advisory Committee, and Chair of Medicine at the University of Louisville. "This important work may lead to new approaches to the treatment o
|Contact: Nathaniel Dunford|
American Thoracic Society